Comparison of two approaches to basal-bolus insulin therapy in patients with type 2 diabetes and inadequate glycemic control on oral therapy: comparison of premixed insulin lispro mid mixture with separate basal and bolus insulin injections.
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Insulin glargine; Insulin lispro; Insulin neutral protamine lispro/insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms IOOX
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 17 Dec 2009 Patient numbers amended from 469 to 484 as reported by ClinicalTrials.gov.
- 21 Oct 2009 Results presented at the 20th World Diabetes Congress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History